Physiology and Pathophysiology of the Human Sympathoadrenal Neuroendocrine System

New England Journal of Medicine

Volumn 303, Issue 8, 1980, Pages 436-444

  Bleich, Howard L ^a   Moore, Mary Jean ^a   Cryer, Philip E ^b  

^a Washington University School of Medicine ^*

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC SYSTEM; AUTONOMIC NERVOUS SYSTEM; CARBOHYDRATE METABOLISM; CARDIOVASCULAR SYSTEM; ENDOCRINE SYSTEM; PHEOCHROMOCYTOMA; PHYSIOLOGY; PROTEIN METABOLISM; REVIEW;

ADRENAL GLAND NEOPLASMS; ADRENAL GLANDS; ANIMAL; CARBOHYDRATES; CATECHOLAMINES; CHILD; DIABETES MELLITUS; DIABETIC NEUROPATHIES; DYSAUTONOMIA, FAMILIAL; HUMAN; HYPERTENSION; HYPOTENSION, ORTHOSTATIC; LIPIDS; MYOCARDIAL INFARCTION; PHEOCHROMOCYTOMA; PROTEINS; RATS; RECEPTORS, ADRENERGIC, ALPHA; RECEPTORS, ADRENERGIC, BETA; SUPPORT, U.S. GOV'T, P.H.S.; SYMPATHETIC NERVOUS SYSTEM;

EID: 0018971649     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198008213030806     Document Type: Review

References (68)

1. Cryer P.E. Isotope-derivative measurements of plasma norepinephrine and epinephrine in man. Diabetes. 1976; 25:1071-1082.
2. Silverberg A.B., Shah S.D., Haymond M.W., Cryer P.E. Norepinephrine: hormone and neurotransmitter in man. Am J Physiol. 1978; 234:E252-6.
3. Engelman K., Portnoy B., Lovenberg W. A sensitive and specific double-isotope derivative method for the determination of catecholamines in biological specimens. Am J Med Sci. 1968; 255:259-268.
4. Engelman K., Portnoy B. A sensitive double-isotope derivative assay for norepinephrine and epinephrine: normal resting human plasma levels. Circ Res. 1970; 26:53-57.
5. Passon P.G., Peuler J.D. A simplified radiometric assay for plasma norepinephrine and epinephrine. Anal Biochem. 1973; 51:618-631.
6. Schade D.S., Eaton R.P. The regulation of plasma ketone body concentration by counter-regulatory hormones in man. III. Effects of norepinephrine in normal man. Diabetes. 1979; 28:5-10.
7. Garber A.J., Karl I.E., Kipnis D.M. Alanine and glutamine synthesis and release from skeletal muscle. IV. β-adrenergic inhibition of amino acid release. J Biol Chem. 1976; 251:1851-1857.
8. Clutter W., Bier D., Shah S., Cryer P. Epinephrine: plasma metabolic clearance rates and physiologic thresholds for metabolic and hemo-dynamic actions in man. J Clin Invest. 1980; 66:94-101.
9. Shamoon H., Jacob R., Sherwin R.S. Epinephrine-induced hypoamino-acidemia in man: a β-adrenergic effect. Clin Res. 1979; 27:595A. abstract.
10. Rizza R., Haymond M., Cryer P., Gerich J. Differential effects of epinephrine on glucose production and disposal in man. Am J Physiol. 1979; 237:E356-62.
11. Rizza R.A., Cryer P.E., Haymond M.W., Gerich J.E. Adrenergic mechanisms for the effects of epinephrine on glucose production and clearance in man. J Clin Invest. 1980; 65:682-689.
12. Garber A.J., Cryer P.E., Santiago J.V., Haymond M.W., Pagliara A.S., Kipnis D.M. The role of adrenergic mechanisms in the substrate and hormonal response to insulin-induced hypoglycemia in man. J Clin Invest. 1976; 58:7-15.
13. Clarke W.L., Santiago J.V., Thomas L., Ben-Galim E., Haymond M.W., Cryer P.E. Adrenergic mechanisms in recovery from hypoglycemia in man: adrenergic blockade. Am J Physiol. 1979; 236:E147-52.
14. Gerich J., Davis J., Lorenzi M., et al. Hormonal mechanisms of recovery from insulin-induced hypoglycemia in man. Am J Physiol. 1979; 236:E380-5.
15. Rizza R.A., Cryer P.E., Gerich J.E. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation: effects of soma-tostatin and combined α-and β-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia. J Clin Invest. 1979; 64:62-71.
16. Santiago J.V., Clarke W.L., Shah S.D., Cryer P.E. Activation of glucose counter-regulatory systems in association with physiologic decrements in plasma glucose in normal and diabetic man. Clin Res. 1980; 28:522A. abstract.
17. Hamburg S., Hendler R., Sherwin R.S. Epinephrine: exquisite sensitivity to its diabetogenic effects in normal man. Clin Res. 1979; 27:252A. abstract.
18. Iversen L.L. Uptake processes for biogenic amines. In: Iversen LL, Iversen SD, Snyder SH, eds. Handbook of psychopharmacology. Section 1, Vol. 3. New York: Plenum Press, 1975: 381-442.
19. Cryer P.E., Rizza R.A., Haymond M.W., Gerich J.E. Epinephrine and norepinephrine are cleared through beta-adrenergic, but not alpha-adrenergic, mechanisms in man. Metabolism, (in press).
20. Wrenn S., Homey C., Haber E. Evidence for the β-adrenergic receptor regulation of membrane-bound catechol-O-methyltransferaseee activity in myocardium. J Biol Chem. 1979; 254:5708-5712.
21. Eisenfeld A.J., Axelrod J., Krakoff L. Inhibition of the extraneuronal accumulation and metabolism of norepinephrine by adrenergic blocking agents. J Pharmacol Exp Ther. 1967; 156:107-113.
22. Richards D.A., Prichard B.N.C., Dobbs R.J. Adrenoceptor blockade of the circulatory responses to intravenous isoproterenol. Clin Pharmacol Ther. 1978; 24:264-273.
23. Lefkowitz R.J. Direct binding studies of adrenergic receptors: biochemical, physiologic, and clinical implications. Ann Intern Med. 1979; 91:450-458.
24. Galant S.P., Duriseti L., Underwood S., Insel P.A. Decreased beta-adrenergic receptors on polymorphonuclear leukocytes after adrenergic therapy. N Eng) J Med. 1978; 299:933-936.
25. Tohmeh J.F., Cryer P.E. Biphasic adrenergic modulation of β-adrenergic receptors in man: agonist-induced early increment and late decrement in β-adrenergic receptor number. J Clin Invest. 1980; 65:836-840.
26. Hirata F., Strittmatter W.J., Axelrod J. β-Adrenergic receptor agonists increase phospholipid methylation, membrane fluidity, and β-adrenergic receptor-adenylate cyclase coupling. Proc Natl Acad Sci USA. 1979; 76:36-72.
27. Strittmatter W.J., Hirata F., Axelrod J. Phospholipid methylation unmasks cryptic β-adrenergic receptors in rat reticulocytes. Science. 1979; 204:1205-1207.
28. Starke K., Taube H.D., Borowski E. Presynaptic receptor systems in catecholaminergic transmission. Biochem Pharmacol. 1977; 26:259-268.
29. Engelman K., Portnoy B., Sjoerdsma A. Plasma catecholamine concentrations in patients with hypertension. Circ Res. 1970; 27: Suppl 1:1141-1145.
30. Geffen L.B., Rush R.A., Louis W.J., Doyle A.E. Plasma catecholamine and dopamine β-hydroxylase amounts in phaeochromocytoma. Clin Sci. 1973; 44:421-424.
31. Cryer P.E. Pheochromocytoma and autonomic dysfunction. Arch Intern Med. 1977; 137:783-787.
32. Ganguly A., Henry D.P., Yune H.Y., et al. Diagnosis and localization of pheochromocytoma: detection by measurement of urinary norepinephrine excretion during sleep, plasma norepinephrine concentration and computerized axial tomography (CT-scan). Am J Med. 1979; 67:21-26.
33. Feldman J.M., Blalock J.A., Farrell R.E., Wells S.A. Jr. Plasma norepinephrine response to standing in patients with pheochromocytoma or medullary carcinoma of the thyroid. Arch Intern Med. 1979; 139:81-85.
34. Bravo E.L., Tarazi R.C., Gifford R.W., Stewart B.H. Circulating and urinary catecholamines in pheochromocytoma: diagnostic and patho-physiologic implications. N Engl J Med. 1979; 301:682-686.
35. Aronoff S.L., Passamani E., Borowsky B.A., Weiss A.N., Roberts R., Cryer P.E. Norepinephrine and epinephrine secretion from a clinically epinephrine secreting pheochromocytoma. Am J Med. (in press).
36. Cryer P.E., Santiago J.V., Shah S. Measurement of norepinephrine and epinephrine in small volumes of human plasma by a single isotope derivative method: response to the upright posture. J Clin Endocrinol Metab. 1974; 39:1025-1029.
37. Cryer P.E. Mechanisms and management of postural hypotension. In: Cohen MP, Foà PP, eds. Special topics in endocrinology and metabolism. Vol. 1. New York: Alan R Liss, 1979: 79-91.
38. Tohmeh J.F., Shah S.D., Cryer P.E. The pathogenesis of hyperadrenergic postural hypotension in diabetic patients. Am J Med. 1979; 67:772-778.
39. Silverberg A.B., Mennes P.A., Cryer P.E. Resistance to endogenous norepinephrine in Bartter#x0027;s syndrome: reversion during indomethacin administration. Am J Med. 1978; 64:231-235.
40. Cryer P.E., Weiss S. Reduced plasma norepinephrine response to standing in autonomic dysfunction. Arch Neurol. 1976; 33:275-277.
41. Ziegler M.G., Lake C.R., Kopin I.J. The sympathetic-nervous-system defect in primary orthostatic hypotension. N Engl J Med. 1977; 296:293-297.
42. Leveston S.A., Shah S.D., Cryer P.E. Cholinergic stimulation of norepinephrine release in man: evidence of a sympathetic postganglionic axonal lesion in diabetic adrenergic neuropathy. J Clin Invest. 1979; 64:374-380.
43. Philipp Th, Distler A., Cordes U. Sympathetic nervous system and blood-pressure control in essential hypertension. Lancet. 1978; 2:959-963.
44. Christensen N.J. Plasma norepinephrine and epinephrine in untreated diabetics, during fasting and after insulin administration. Diabetes. 1974; 23:1-8.
45. Tamborlane W.V., Sherwin R.S., Koivisto V., Hendler R., Genel M., Felig P. Normalization of the growth hormone and catecholamine response to exercise in juvenile-onset diabetic subjects treated with a portable insulin infusion pump. Diabetes. 1979; 28:785-788.
46. Cryer P.E., Silverberg A.B., Santiago J.V., Shah S.D. Plasma catecholamines in diabetes: the syndromes of hypoadrenergic and hyperadrenergic postural hypotension. Am J Med. 1978; 64:407-416.
47. Shamoon H., Hendler R., Sherwin R.S. Altered responsiveness to Cortisol, epinephrine, and glucagon in insulin-infused juvenile-onset diabetics: a mechanism for diabetic instability. Diabetes. 1980; 29:284-291.
48. Christensen N.J., Videbaek J. Plasma catecholamines and carbohydrate metabolism in patients with acute myocardial infarction. J Clin Invest. 1974; 54:278-286.
49. Karlsberg R.P., Cryer P.E., Roberts R. Early adrenergic response to myocardial infarction: relation to myocardial damage and late mortality. Clin Res. 1979; 27:178A. abstract.
50. Karlsberg R.P., Penkoske P.A., Cryer P.E., Corr P.B., Roberts R. Rapid activation of the sympathetic nervous system following coronary artery occlusion: relationship to infarct size, site, and haemodynamic impact. Cardiovasc Res. 1979; 13:523-531.
51. Lown B., Verrier R.L. Neural activity and ventricular fibrillation. N EngI J Med. 1976; 294:1165-1170.
52. Mudge G.H. Jr., Grossman W., Mills R.M. Jr., Lesch M., Braunwald E. Reflex increase in coronary vascular resistance in patients with ischemic heart disease. N Engl J Med. 1976; 295:1333-1337.
53. Cryer P.E., Haymond M.W., Santiago J.V., Shah S.D. Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N Engl J Med. 1976; 295:573-577.
54. Bellet S., DeGuzman N.T., Kostis J.B., Roman L., Fleischmann D. The effect of inhalation of cigarette smoke on ventricular fibrillation threshold in normal dogs and dogs with acute myocardial infarction. Am Heart J. 1972; 83:67-76.
55. Improvement in prognosis of myocardial infarction by long-term beta-adrenoreceptor blockade using practolol: a Multicentre International Study. Br Med J. 1975; 3:735-740.
56. Norris R.M., Clarke E.D., Sammel N.L., Smith W.M., Williams B. Protective effect of propranolol in threatened myocardial infarction. Lancet. 1978; 2:907-909.
57. Kahn C.R. Membrane receptors for hormones and neurotransmitters. J Cell Biol. 1976; 70:261-286.
58. Lefkowitz R.J. Direct binding studies of adrenergic receptors: biochemical, physiologic, and clinical implications. Ann Intern Med. 1979; 91:450-458.
59. Baxter J.D., Funder J.W. Hormone receptors. N Engl J Med. 1979; 301:1149-1161.
60. Venter J.C. High efficiency coupling between beta-adrenergic receptors and cardiac contractility: direct evidence for “spare” beta-adrenergic receptors. Mol Pharmacol. 1979; 16:429-440.
61. Young J.B., Landsberg L. Suppression of sympathetic nervous system during fasting. Science. 1977; 196:1473-1475.
62. Landsberg L., Young J.B. Fasting, feeding and regulation of the sympathetic nervous system. N Engl J Med. 1978; 298:1295-1301.
63. Young J.B., Landsberg L. Effect of diet and cold exposure on norepinephrine turnover in pancreas and liver. Am J Physiol. 1979; 236:E524-33.
64. Young J.B., Landsberg L. Sympathoadrenal activity in fasting pregnant rats: dissociation of adrenal medullary and sympathetic nervous system responses. J Clin Invest. 1979; 64:109-116.
65. Jung R.T., Shetty P.S., Barrand M., Callingham B.A., James W.P.T. Role of catecholamines in hypotensive response to dieting. Br Med J. 1979; 1:12-13.
66. Gross H.A., Lake C.R., Ebert M.H., Ziegler M.G., Kopin I.J. Catecholamine metabolism in primary anorexia nervosa. J Clin Endocrinol Metab. 1979; 49:805-809.
67. DeHaven J., Sherwin R., Hendler R., Felig P. Nitrogen and sodium balance and sympathetic-nervous-system activity in obese subjects treated with a low-calorie protein or mixed diet. N Engl J Med. 1980; 302:477-482.
68. Galbo H., Holst J.J., Christensen N.J. Glucagon and plasma catecholamine responses to graded and prolonged exercise in man, J Appl Physiol. 1975; 38:70-76.